FDA
approval
· 2016-09-15
FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
Summary
FDA approved the supplemental application for STRIBILD (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) from Gilead Sciences, Inc. T…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for STRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE)